Clinical Trial

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Name: Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia — clinical trial record (NCT07397325)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2026-02-02; most recent amendment 2026-04-08.

Trial Details

NCT Number	NCT07397325
Lead Sponsor	Applied Biology, Inc. Collaborators: Daniel Alain, Inc., Follea International Limited
Conditions	Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Enrollment	60 participants
Start Date	2026-04-16
Primary Completion	2026-10-05 (estimated)
Study Completion	2026-12-07 (estimated)
Updated on ClinicalTrials.gov	2026-04-13